Inhaled insulin for diabetes mellitus
- 1 July 2005
- journal article
- review article
- Published by Oxford University Press (OUP) in American Journal of Health-System Pharmacy
- Vol. 62 (13) , 1359-1364
- https://doi.org/10.2146/ajhp040249
Abstract
Purpose. Pharmacokinetic and safety data related to the use of inhaled insulin for the management of diabetes mellitus are discussed. The various pulmonary insulin delivery systems under development are also reviewed.Keywords
This publication has 25 references indexed in Scilit:
- Pharmacokinetics and Acute Safety of Inhaled Testosterone in Postmenopausal WomenThe Journal of Clinical Pharmacology, 2005
- Inhaled insulin for the treatment of diabetes: projects and devicesExpert Opinion on Pharmacotherapy, 2003
- Inhaled insulin – a new therapeutic option in the treatment of diabetes mellitusExpert Opinion on Pharmacotherapy, 2003
- Recent Advances in the Development of an Inhaled Insulin ProductBioDrugs, 2003
- Variability of Insulin Absorption and Insulin ActionDiabetes Technology & Therapeutics, 2002
- Inhaled Insulin and Insulin Antibodies: A New Twist to an Old DebateDiabetes Technology & Therapeutics, 2002
- TechnosphereTM/Insulin - proof of concept study with a new insulin formulation for pulmonary deliveryExperimental and Clinical Endocrinology & Diabetes, 2002
- Efficacy of inhaled human insulin in type 1 diabetes mellitus: a randomised proof-of-concept studyThe Lancet, 2001
- The Lung As an Alternative Route of Delivery for Insulin in Controlling Postprandial Glucose Levels in Patients With DiabetesChest, 1998
- Monomeric Insulins and Their Experimental and Clinical ImplicationsDiabetes Care, 1990